Variable | Saturated model | Stepwise model | ||
---|---|---|---|---|
b (95% CI) | P-value | b (95% CI) | P-value | |
Increase in no. of new nodules for each additional initial nodulea | ||||
Annual treatment | 0.055 (0.030–0.080) | < 0.001 | 0.058 (0.035–0.081) | < 0.001 |
3-monthly treatment | 0.023 (0.0004–0.046) | 0.045 | 0.026 (0.005–0.048) | 0.014 |
Age | 0.005 (0.0001–0.010) | 0.045 | 0.006 (0.002–0.009) | 0.002 |
Weight | − 0.007 (− 0.005–0.003) | 0.703 | ||
CMFL in the village of residence | ||||
Low | Ref. | |||
Middle | 0.089 (− 0.153–0.332) | 0.470 | ||
High | 0.149 (− 0.074–0.372) | 0.191 | ||
MFD | ||||
0–30 mf/mg | Ref. | Ref. | ||
31–80 mf/mg | 0.084 (− 0.108–0.277) | 0.389 | 0.102 (− 0.081–0.285) | 0.275 |
81–170 mf/mg | 0.265 (0.082–0.447) | 0.004 | 0.290 (0.117–0.463) | 0.001 |
> 171 mf/mg | 0.358 (0.181–0.535) | < 0.001 | 0.383 (0.217–0.550) | < 0.001 |
P of the model | < 0.001 | < 0.001 | ||
AIC | 1648 | 1644 | ||
BIC | 1686 | 1669 | ||
Log likelihood | − 815.2 | − 816.3 |